Cavernoma Management Update: Cavernomas A Randomised Effectiveness CARE Trial publication overview

Description

Join us for an insightful webinar featuring distinguished experts from National Hospital for Neurology and Neurosurgery, Queen Square London, and Thornbury Radiosurgery Centre, Sheffield. This webinar will provide you with information on the latest approaches to Cavernoma management and an analysis of the findings from the Cavernomas A Randomised Effectiveness (CARE) trial, recently published in The Lancet Neurology.

AGENDA

Introductions: Mr Patrick Grover

Overview of Sheffield Experience of Cavernoma Management: Mr Matthias Radatz

The CARE trial results: Prof Rusty Al-Shahi

Patient perspective and experience: Mr Ben Brady

Live discussion and Q&A: chaired by Mr Patrick Grover

LEARNING OBJECTIVES

Understanding the Current Management of Cavernomas: Gain comprehensive knowledge of the standard management approaches for cavernomas, including when intervention may be necessary and the various treatment options available.

Exploring the Latest Findings from the CARE Trial: Get an in-depth update on the recent results of the Cavernomas A Randomised Effectiveness (CARE) trial, as published in The Lancet Neurology, and understand their implications for clinical practice.

Experiencing the Patient’s Perspective in Cavernoma Management: Learn from the patient's viewpoint about living with cavernomas and how different management strategies impact their quality of life and treatment outcomes.